ERF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.650200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.876200E-01
Normal-vs-Stage2
6.987200E-01
Normal-vs-Stage3
9.122200E-01
Normal-vs-Stage4
5.635700E-02
Stage1-vs-Stage2
9.269000E-01
Stage1-vs-Stage3
6.054400E-01
Stage1-vs-Stage4
3.000200E-02
Stage2-vs-Stage3
5.287800E-01
Stage2-vs-Stage4
1.000730E-03
Stage3-vs-Stage4
7.685600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.834800E-01
Normal-vs-AfricanAmerican
4.278600E-01
Normal-vs-Asian
3.860200E-01
Caucasian-vs-AfricanAmerican
3.926000E-01
Caucasian-vs-Asian
3.717800E-01
AfricanAmerican-vs-Asian
8.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.221400E-01
Normal-vs-Female
6.124800E-01
Male-vs-Female
4.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.929600E-01
Normal-vs-Age(41-60Yrs)
5.274400E-01
Normal-vs-Age(61-80Yrs)
6.912000E-01
Normal-vs-Age(81-100Yrs)
9.262200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.414600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.176800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.733200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.538600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.826630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.216800E-01
Normal-vs-Daily Drinker
3.504400E-01
Normal-vs-Weekly Drinker
3.923600E-01
Normal-vs-Occasional Drinker
4.564600E-01
Normal-vs-Social Drinker
9.389200E-01
Non Drinker-vs-Daily Drinker
2.609200E-01
Non Drinker-vs-Weekly Drinker
1.514550E-01
Non Drinker-vs-Occasional Drinker
5.111000E-01
Non Drinker-vs-Social Drinker
4.095800E-01
Daily Drinker-vs-Weekly Drinker
5.442600E-01
Daily Drinker-vs-Occasional Drinker
6.781600E-01
Daily Drinker-vs-Social Drinker
6.601800E-02
Weekly Drinker-vs-Occasional Drinker
3.903400E-01
Weekly Drinker-vs-Social Drinker
8.489700E-02
Occasional Drinker-vs-Social Drinker
1.510960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.335200E-01
Normal-vs-Grade 2
1.019610E-01
Normal-vs-Grade 3
8.386300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.877700E-02
Grade 1-vs-Grade 3
5.584500E-02
Grade 1-vs-Grade 4
2.335200E-01
Grade 2-vs-Grade 3
9.910400E-01
Grade 2-vs-Grade 4
1.019610E-01
Grade 3-vs-Grade 4
8.386300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.928400E-01
Normal-vs-NonDiabetic
5.503600E-01
Diabetic-vs-NonDiabetic
2.590600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.960000E-01
Normal-vs-NoPancreatitis
6.727800E-01
Pancreatitis-vs-NoPancreatitis
5.510000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.716200E-01
Normal-vs-N1
6.807000E-01
N0-vs-N1
6.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.872200E-01
Normal-vs-TP53-NonMutant
5.708600E-01
TP53-Mutant-vs-TP53-NonMutant
4.588100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
